Revance Therapeutics shares owned by Commonwealth Equity Services
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Commonwealth Equity Services
from 13F filings
Historical chart of Commonwealth Equity Services investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Commonwealth Equity Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $977k | 111k | 8.79 |
| 2023-09-30 | $1.1M | 99k | 11.47 |
| 2023-06-30 | $2.4M | 96k | 25.31 |
| 2023-03-31 | $2.9M | 89k | 32.21 |
| 2022-12-31 | $1.6M | 89k | 18.45 |
| 2022-09-30 | $2.0M | 76k | 27.00 |
| 2022-06-30 | $453k | 33k | 13.81 |
| 2022-03-31 | $591k | 30k | 19.50 |
| 2021-12-31 | $403k | 25k | 16.31 |
| 2021-09-30 | $589k | 21k | 27.84 |
| 2021-06-30 | $448k | 15k | 29.60 |
| 2021-03-31 | $427k | 15k | 27.94 |
| 2020-12-31 | $373k | 13k | 28.30 |
| 2020-09-30 | $316k | 13k | 25.09 |
More positions owned by Commonwealth Equity Services
View all positions for Commonwealth Equity Services